Payam Mehrian
Overview
Explore the profile of Payam Mehrian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Behnam-Manesh H, Doroudinia A, Bayat M, Bakhshayesh Karam M, Salimi B, Nejabat M, et al.
Clin Nucl Med
. 2023 Nov;
49(1):e40-e41.
PMID: 37976528
Radiolabeled fibroblast activation protein inhibitors (FAPIs) have been extensively used in different types of cancers, although not yet FDA approved. Normal patterns of FAPI biodistribution have been investigated, and it...
2.
Bayat M, Doroudinia A, Bakhshayesh Karam M, Mehrian P
Clin Nucl Med
. 2022 Oct;
48(3):271-272.
PMID: 36252811
Immune checkpoint inhibitors are a new and different treatment option in many of solid tumors, but with many recognized immune-related adverse side effects. In this interesting image, we are presenting...
3.
Mehrian P, Kiani A, Bandegani N, Razavi F, Moazzezi S, Rostami Y, et al.
Pol J Radiol
. 2021 Nov;
86:e542-e547.
PMID: 34820030
Purpose: Eosinophilic lung diseases are a group of pulmonary disorders associated with peripheral or tissue eosinophilia. They can be classified into primary (idiopathic) and secondary groups based on their aetiology....
4.
Shadmehr M, Khosravi A, Abbasi Dezfouli A, Bakhshayesh-Karam M, Jamaati H, Doroudinia A, et al.
Tanaffos
. 2021 Apr;
19(3):186-194.
PMID: 33815538
Background: An initial evaluation of non-small cell lung cancer (NSCLC) patients with 18F- fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan can modify treatment planning. We investigated the clinical significance...
5.
Mortaz E, Bassir A, Dalil Roofchayee N, Dezfuli N, Jamaati H, Tabarsi P, et al.
Int Immunopharmacol
. 2021 Feb;
93:107407.
PMID: 33631512
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has infected 86,4 M patients and resulted in 1,86 M deaths worldwide. Severe COVID-19 patients have...
6.
Mehrian P, Iranpour P, Haseli S, Khalili N
Rev Cardiovasc Med
. 2021 Jan;
21(4):493-495.
PMID: 33387992
No abstract available.
7.
Doroudinia A, Mehrian P, Rouhizadeh A, Hosseini M
Clin Nucl Med
. 2020 Nov;
46(4):e226-e227.
PMID: 33234923
We present a 14-year-old adolescent boy with Hodgkin lymphoma. He had prior completed chemotherapy with ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) regimen followed by bone marrow transplantation 6 months ago. Currently,...
8.
Mortezaee V, Mahdaviani S, Pourabdollah M, Hassanzad M, Mirenayat M, Mehrian P, et al.
Mycoses
. 2020 Nov;
64(3):272-281.
PMID: 33219548
Background: Allergic bronchopulmonary aspergillosis (ABPA) has been reported in various degrees among patients with persistent allergic asthma (PAA). Currently, there is no gold standard approach for diagnosis of ABPA. Objectives:...
9.
Shobeirian F, Mehrian P, Doroudinia A
Prague Med Rep
. 2020 Oct;
121(3):133-141.
PMID: 33030142
Hypersensitivity pneumonitis (HP) is an immune-mediated diffuse parenchymal lung disease induced by inhaled antigens. High-resolution computed tomography (HRCT) is widely used in the diagnosis and follow-up of patients and determining...
10.
Davarpanah A, Mahdavi A, Sabri A, Faghihi Langroudi T, Kahkouee S, Haseli S, et al.
J Am Coll Radiol
. 2020 Mar;
17(6):734-738.
PMID: 32208138
No abstract available.